AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31915235
Drug: VA-dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VA-dual therapy
Trial: 31915235
Drug: VAC-triple therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAC-triple therapy
Trial: 29426008
Drug: Colchicine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.5 mg twice-daily)
Trial: 16800099
Drug: Topical nimesulide
RxNorm normalized name: nimesulide Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nimesulide gel (Sulidin gel 1%)
Trial: 23688323
Drug: Dupilumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dupilumab (300 mg)
Trial: 24295556
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 μg once-daily (OD)
Trial: 24295556
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 μg OD
Trial: 12608492
Drug: Naltrexone 100
RxNorm normalized name: naltrexone 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 100 mg/day
Trial: 18384246
Drug: Naltrexone 150
RxNorm normalized name: METHYLNALTREXONE 150MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 150 mg/day
Trial: 10960002
Drug: Acetabular augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetabular augmentation screws or offset acetabular liners
Trial: 9303395
Drug: Ceftriaxone and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone and/or cefuroxime axetil (1 to 2 g once to twice daily and 500 mg twice daily respectively)
Trial: 8347269
Drug: Cyclosporin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (10 mg/kg p.o.) administered 6 hours prior to transplant surgery
Trial: 22944906
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion
Trial: 3010693
Drug: Atenolol (beta‐adrenoceptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (beta‐adrenoceptor antagonist)
Trial: 2574496
Drug: Timolol (non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol (non-selective beta blocker)
Trial: 113217
Drug: Propranolol (non-selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (non-selective beta blocker)
Trial: 30219705
Drug: Theophylline 250
RxNorm normalized name: theophylline 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 250 mg
Trial: 22805388
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) therapy, administered three-times weekly for one year
Trial: 22805388
Drug: No rhGH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No rhGH therapy (year before treatment)
Trial: 10351970
Drug: Digoxin (serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (serum concentration, 1.29+/‐0.35 nmol/L)
Trial: 2008268
Drug: Xenon photocoagulation
RxNorm normalized name: xenon
DrugBank: Xenon (DB13453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenon photocoagulation treatment
Trial: 28730694
Drug: RG7697 (0.25-2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7697 (0.25-2.5 mg)
Trial: 28730694
Drug: RG7697 (≥0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7697 (≥0.75 mg)
Trial: 28730694
Drug: RG7697 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7697 (2.5 mg)
Trial: 28730694
Drug: RG7697 (≥1.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7697 (≥1.1 mg)
Trial: 3929301
Drug: d-amphetamine (AMP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (AMP; 10 mg)
Trial: 3929301
Drug: d-amphetamine (AMP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (AMP; 2.5 mg)
Trial: 8799523
Drug: diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (10 mg)
Trial: 24666210
Drug: Spirometry testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirometry testing before and after bronchodilator (BD) using the EasyOne spirometer.
Trial: 22686204
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg daily for 1 year)
Trial: 23140261
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no metformin)
Trial: 18062520
Drug: Midazolam 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.03 mg/kg followed by pethidine 20 mg intravenously
Trial: 12666828
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg selenite daily, increased fish intake (at least three fish dinners weekly)
Trial: 12666828
Drug: Placebo tablets,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets, increased fish intake (at least three fish dinners weekly)
Trial: 12666828
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg Se-methionine daily, increased fish intake (at least three fish dinners weekly)
Trial: 12666828
Drug: No selenium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No selenium supplementation, increased fish intake (at least three fish dinners weekly)
Trial: 2478793
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg t.i.d.)
Trial: 8761775
Drug: 0.1 p.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 p. 100 adapalene gel
Trial: 8761775
Drug: 0.03 p.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 p. 100 adapalene gel
Trial: 8761775
Drug: 0.025 p.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 p. 100 tretinoin gel
Trial: 6118121
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol for 3 days
Trial: 19442491
Drug: Immediate discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate discontinuation of current antipsychotic with aripiprazole (10 mg)
Trial: 17880369
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g agar
Trial: 17880369
Drug: 5.2 g
RxNorm normalized name: Veltassa 25.2 GM Powder for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.2 g pectin
Trial: 11257337
Drug: CAIV-T vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAIV-T vaccine
Trial: 22324182
Drug: Systemic family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic family therapy (SB; exclusively verbal)
Trial: 19415994
Drug: Levothyroxine (LT(4))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine (LT(4)) treatment in OH group
Trial: 10921125
Drug: Abstinence capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence capsule
Trial: 23996473
Drug: Single intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravenous (iv) doses of blosozumab up to 750 mg
Trial: 23996473
Drug: Single subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subcutaneous (sc) doses of blosozumab 150 mg
Trial: 22024822
Drug: Intravenous doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous doxycycline (40 to 200 mg)
Trial: 22024822
Drug: Doxycycline (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (intravenous and oral)
Trial: 20716558
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) alone
Trial: 20716558
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clomiphene citrate (CC) plus metformin
Trial: 10071274
Drug: 8-in-1 chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-in-1 chemotherapy before and after XRT
Trial: 7570323
Drug: OLT candidates
RxNorm normalized name: FINLAY-FR-1 anti-SARS-CoV-2 vaccine candidate
DrugBank: FINLAY-FR-1 (DB16524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLT candidates after volume infusion (1 L of crystalloid)
Trial: 12777271
Drug: Long-acting risperidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting risperidone 25 mg
Trial: 12777271
Drug: Long-acting risperidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting risperidone 50 mg
Trial: 16965196
Drug: Long-acting risperidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting risperidone 25 mg and 50 mg
Trial: 8986186
Drug: Intra-articular tenoxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular tenoxicam 20 mg in 20 ml of normal saline
Trial: 23489210
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg zanamivir
Trial: 23489210
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg zanamivir
Trial: 19562574
Drug: 32 g
RxNorm normalized name: PEG-32 Glyceryl Laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 g liquorice alone for 2 weeks
Trial: 19562574
Drug: 32 g
RxNorm normalized name: PEG-32 Glyceryl Laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 32 g liquorice combined with 25 mg hydrochlorothiazide for 2 weeks
Trial: 7852228
Drug: Aspirin 325mg
RxNorm normalized name: ASPIRIN 325MG CAP
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325mg (group A, n = 12)
Trial: 7852228
Drug: Aspirin 160mg
RxNorm normalized name: Premier Value Jr. Non-Aspirin 160mg Quick Melt (Grape)
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 160mg (group B, n = 16)
Trial: 2894232
Drug: Aspirin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (both doses)
Trial: 2508483
Drug: Dopamine (DA)
DrugBank: Dopamine (DB00988)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dopamine (DA) infusion at 2.5 micrograms.kg‐1.min‐1
Trial: 2508483
Drug: Dopamine (DA)
DrugBank: Dopamine (DB00988)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dopamine (DA) infusion at 10 micrograms.kg‐1.min‐1
Trial: 16822105
Drug: 12-session group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-session group cognitive-behavioral therapy (CBT)
Trial: 10512903
Drug: Supplemental oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplemental oxygen treatment (100% oxygen, 3 L/min) for 24 hours among patients with SSS scores of <40
Trial: 7793298
Drug: Insulin sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitivity in non-obese FH subgroup
Trial: 7793298
Drug: Correlation between
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Correlation between insulin and BMI
Trial: 7793298
Drug: Hormonal parameters
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal parameters including insulin
Trial: 2029134
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of flucloxacillin and metronidazole
Trial: 7270617
Drug: Intrauterine irrigation
RxNorm normalized name: Intrauterine System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine irrigation with normal saline solution
Trial: 24927436
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment without probiotics
Trial: 29659416
Drug: PICU Soothing
RxNorm normalized name: Dermal-Soothe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PICU Soothing intervention (parental comforting with touch and reading, followed by music via soft headbands, administered once daily throughout hospitalization)
Trial: 10629708
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy or hormone therapy with tamoxifen
Trial: 7782525
Drug: Pulsed Nd:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Nd: YAG laser treatment (113 mJ pulses at 15 pulses s‐1 for 3 min)
Trial: 30346026
Drug: Nitrous oxide
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrous oxide (N2 O) inhalation
Trial: 30188494
Drug: Low Exposure
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Exposure (250 μg/m)
Trial: 30188494
Drug: High Exposure
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Exposure (500 μg/m)
Trial: 22162541
Drug: MK-5046 (10-160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-5046 (10-160 mg)
Trial: 20306334
Drug: Spoon administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spoon administration of Oral Rehydration Solutions (ORS)
Trial: 20306334
Drug: Nasogastric tube
RxNorm normalized name: nasogastric tube
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasogastric tube administration of Oral Rehydration Solutions (ORS)
Trial: 17608314
Drug: Low-dose methylphenidate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methylphenidate (0.3 mg/kg/dose)
Trial: 17608314
Drug: High-dose methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylphenidate (0.5 mg/kg/dose)
Trial: 15651051
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (1000 mg)
Trial: 15651051
Drug: Lithium (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (900 mg)
Trial: 12393361
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate 30 mg kg(‐1) as a bolus before induction and 10 mg kg(‐1) h(‐1) by continuous i.v. infusion during the operation
Trial: 15653705
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (isotonic solution)
Trial: 1719729
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (infusion of Ringer lactate)
Trial: 30442251
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg kg‐1 S-ketamine
Trial: 30442251
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg kg‐1 S-ketamine
Trial: 16372229
Drug: hGH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hGH treatment for 24 months
Trial: 2684383
Drug: Doxorubicin (DX)
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxorubicin (DX) 75 mg/m2 IV every 3 weeks
Trial: 2684383
Drug: Idarubicin (IDA)
DrugBank: Idarubicin (DB01177)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Idarubicin (IDA) 45 mg/m2 orally every 3 weeks
Trial: 27645465
Drug: Chiropractic manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic manipulative therapy (CMT) - four treatments over 2 weeks
Trial: 27645465
Drug: Wait-list control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait-list control group - no treatment
Trial: 22302849
Drug: Fixed-dose artesunate-amodiaquine
RxNorm normalized name: Amodiaquine
DrugBank: Amodiaquine (DB00613)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fixed-dose artesunate-amodiaquine regimen
Trial: 23248072
Drug: Opicapone 25
RxNorm normalized name: opicapone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opicapone 25 mg
Trial: 28240566
Drug: Bayesian adaptive
RxNorm normalized name: Babesia microti preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bayesian adaptive randomization treatment regimens
Trial: 23826760
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of oral sodium bicarbonate with a serum target HCO3- level of 24±1 mmol/L
Trial: 23826760
Drug: Rescue therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue therapy of sodium bicarbonate with a serum target level of 20±1 mmol/L
Trial: 23826760
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of oral sodium bicarbonate
Trial: 23826760
Drug: Rescue therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue therapy of sodium bicarbonate
Trial: 16877721
Drug: rhEndostatin administered
RxNorm normalized name: Pentostatin
DrugBank: Pentostatin (DB00552)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rhEndostatin administered as a bid subcutaneous injection at a starting dose of 60 mg/m2/d, escalated to 90 mg/m2/d if necessary
Trial: 18184901
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg
Trial: 11386930
Drug: Intravenous alpha‐gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alpha‐gal A (0.2 mg/kg every other week for 12 doses)
Trial: 6403000
Drug: Oral neomycin
RxNorm normalized name: neomycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral neomycin and erythromycin base plus parenteral placebo
Trial: 6403000
Drug: Oral neomycin
RxNorm normalized name: neomycin Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral neomycin and erythromycin base plus parenteral cephalothin sodium
Trial: 28283937
Drug: Bisphosphonate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisphosphonate treatment initiated at 2 weeks after hemiarthroplasty
Trial: 2911877
Drug: Supine position
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supine position with 1 mg bumethanide intravenously
Trial: 2911877
Drug: Upright position
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upright position with 1 mg bumethanide intravenously
Trial: 381093
Drug: Antacid
RxNorm normalized name: Antacid
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antacid
Trial: 31417013
Drug: Targeted antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted antibiotics (TA) based on rectal swab culture
Trial: 31417013
Drug: Empirical antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empirical antibiotics (EA) - standard parenteral ciprofloxacin
Trial: 28099054
Drug: Noninvasive interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Noninvasive interventions (e.g., blood cultures, medications, imaging)
Trial: 28099054
Drug: Aggressive or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive or invasive options (e.g., dialysis, bronchoscopy, surgical consultation, transfer to ICU)
Trial: 25853370
Drug: Methamphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methamphetamine (10 mg or 20 mg)
Trial: 15181049
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg daily for 6 weeks)
Trial: 9483215
Drug: Sex hormones
RxNorm normalized name: GENITO URINARY SYSTEM AND SEX HORMONES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex hormones
Trial: 3520315
Drug: Hydralazine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (300 mg per day) and Isosorbide dinitrate (160 mg per day)
Trial: 3520315
Drug: Prazosin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (20 mg per day)
Trial: 29861260
Drug: Intensified active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified active treatment with additional mobilization and strength training
Trial: 23230745
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of low dose (0.5 g) cefozopran hydrochloride
Trial: 23230745
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of middle dose (1.0 g) cefozopran hydrochloride
Trial: 23230745
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection of high dose (2.0 g) cefozopran hydrochloride
Trial: 16104440
Drug: Local infiltration
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local infiltration with bupivacaine and pre-incisional intramuscular (IM) ketorolac (group BK)
Trial: 7566405
Drug: Gammaglobulin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gammaglobulin (10 g doses at 3-day intervals)
Trial: 7235737
Drug: Oral retinoid
RxNorm normalized name: tretinoin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral retinoid Ro 10‐9359 (75 mg/d)
Trial: 25597699
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (240 mg)